Evaluation of effects induced by ingesting test foods on fat oxidation at rest. - Evaluation of effects induced by ingesting test foods on fat oxidation at rest.

CPCC Company Limited.0 sites30 target enrollmentDecember 18, 2023

ConditionsHealthy male adults

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy male adults
Sponsor: CPCC Company Limited.
Enrollment: 30
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

December 18, 2023

End Date

September 30, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

Male

Investigators

Sponsor

CPCC Company Limited.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects who have a habit of exercises. (2\) Subjects who can not brethe naturally using an aeromonitor. (3\) with irregular life rhythm (e.g., irregular shift work). (4\) Subjects having habitual alcohol intake. (5\) Subjects having a habit of smoking. (6\) Subjects having irregular eating habits. (7\) Subjects with dieting or planning to diet during this study. (8\) Subjects having serious allergic rhinitis. (9\) Subjects who have periodically used health\-specific / functional / health foods including supplements, which might affect fat metabolism. (10\) Subjects who take affecting medicines (except non affecting painkiller/anti\-inflammatory/external/eyedrops) within a month before the consent. (11\) Subjects having severe anemia (12\) Subjects who have experience illness or deterioration of physical condition due to blood sampling in the past. (13\) Subjects who have difficulty in having blood drawn from a peripheral blood vein. (14\) Subjects with a maximal blood pressure of less than 90 mmHg. (15\) Subjects who donated their blood components and/or whole blood (0\.2 L) within the past 4 weeks. (16\) Subjects who donated their whole blood (0\.4 L) within the past 12 weeks. (17\) Subjects being collected in total of their blood (1\.2 L) within the past 12 months and in this research. (18\) Subjects being under other clinical tests, or partook in those within the past four weeks, or will join those after the consent. (19\) Subjects who meet any of the following: (a) suffering from heart, liver, or kidney disease (including complications of other diseases) (b) having a history of cardiovascular disease (c) diabetes (d) allergic to the test food and required one. (20\) Others who were judged as inappropriate for participation by the principal/sub investigator.